Literature DB >> 32678926

Macrophage dysfunction in cystic fibrosis: Nature or nurture?

Keren B Turton1, Rebecca J Ingram1, Miguel A Valvano1.   

Abstract

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) affect the homeostasis of chloride flux by epithelial cells. This has deleterious consequences, especially in respiratory epithelia, where the defect results in mucus accumulation distinctive of cystic fibrosis. CFTR is, however, also expressed in phagocytic cells, like macrophages. Immune cells are highly sensitive to conditioning by their environment; thus, CFTR dysfunction in epithelia influences macrophages by affecting the lung milieu, but the mutations also appear to be directly consequential for intrinsic macrophage functions. Particular mutations can alter CFTR's folding, traffic of the protein to the membrane and function. As such, understanding the intrinsic effects of CFTR mutation requires distinguishing the secondary effects of misfolded CFTR on cell stress pathways from the primary defect of CFTR dysfunction/absence. Investigations into CFTR's role in macrophages have exploited various models, each with their own advantages and limitations. This review summarizes these methodologic approaches, discussing their physiological correspondence and highlighting key findings. The controversy surrounding CFTR-dependent acidification is used as a case study to highlight difficulties in commensurability across model systems. Recent work in macrophage biology, including polarization and host-pathogen interaction studies, brought into the context of CFTR research, offers potential explanations for observed discrepancies between studies. Moreover, the rapid advancement of novel gene editing technologies and new macrophage model systems makes this assessment of the field's models and methodologies timely.
© 2020 The Authors. Journal of Leukocyte Biology published by Wiley Periodicals LLC on behalf of Society for Leukocyte Biology.

Entities:  

Keywords:  CFTR; cystic fibrosis; macrophage; phagosome

Mesh:

Substances:

Year:  2020        PMID: 32678926     DOI: 10.1002/JLB.4RU0620-245R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Neutrophil Elastase Triggers the Release of Macrophage Extracellular Traps: Relevance to Cystic Fibrosis.

Authors:  Apparao B Kummarapurugu; Shuo Zheng; Jonathan Ma; Shobha Ghosh; Adam Hawkridge; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 7.748

2.  Physical Activity Regulates TNFα and IL-6 Expression to Counteract Inflammation in Cystic Fibrosis Patients.

Authors:  Ersilia Nigro; Rita Polito; Ausilia Elce; Giuseppe Signoriello; Paola Iacotucci; Vincenzo Carnovale; Monica Gelzo; Federica Zarrilli; Giuseppe Castaldo; Aurora Daniele
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

3.  Macrophages from gut-corrected CF mice express human CFTR and lack a pro-inflammatory phenotype.

Authors:  Jonathan L Gillan; Gareth R Hardisty; Donald J Davidson; Robert D Gray
Journal:  J Cyst Fibros       Date:  2021-11-17       Impact factor: 5.527

Review 4.  Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 11.413

5.  CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages.

Authors:  Asmaa Badr; Mostafa Eltobgy; Kathrin Krause; Kaitlin Hamilton; Shady Estfanous; Kylene P Daily; Arwa Abu Khweek; Ahmad Hegazi; Midhun N K Anne; Cierra Carafice; Frank Robledo-Avila; Youssra Saqr; Xiaoli Zhang; Tracey L Bonfield; Mikhail A Gavrilin; Santiago Partida-Sanchez; Stephanie Seveau; Estelle Cormet-Boyaka; Amal O Amer
Journal:  Front Cell Infect Microbiol       Date:  2022-02-16       Impact factor: 6.073

Review 6.  The Potential Causes of Cystic Fibrosis-Related Diabetes.

Authors:  Lise Coderre; Lyna Debieche; Joëlle Plourde; Rémi Rabasa-Lhoret; Sylvie Lesage
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-30       Impact factor: 5.555

7.  Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models.

Authors:  Marco Cafora; Noemi Poerio; Francesca Forti; Nicoletta Loberto; Davide Pin; Rosaria Bassi; Massimo Aureli; Federica Briani; Anna Pistocchi; Maurizio Fraziano
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

8.  CF monocyte-derived macrophages have an attenuated response to extracellular vesicles secreted by airway epithelial cells.

Authors:  Katja Koeppen; Amanda Nymon; Roxanna Barnaby; Zhongyou Li; Thomas H Hampton; Alix Ashare; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-01-20       Impact factor: 6.011

9.  2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.

Authors:  Mao Wang; Alex G Gauthier; Thomas P Kennedy; Haichao Wang; Uday Kiran Velagapudi; Tanaji T Talele; Mosi Lin; Jiaqi Wu; LeeAnne Daley; Xiaojing Yang; Vivek Patel; Sung Soo Mun; Charles R Ashby; Lin L Mantell
Journal:  Mol Med       Date:  2021-07-16       Impact factor: 6.354

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.